PrEP Injectable Could Stop HIV—But Access Barriers Persist
In a potentially major development for ending the HIV epidemic, the FDA has just approved the first long-lasting, injectable form of HIV prevention medication. Apretude, from ViiV Healthcare, is administered as a single shot once every 60 days. Because that makes adherence much easier than taking a daily pill, the injectable proved far more effective […]
